Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b Trial of X4P-001 Alone and With Pembrolizumab in Patients With Advanced Melanoma

NCT02823405 is registered in ClinicalTrials.gov with X4 Pharmaceuticals as lead sponsor.

NCT NCT02823405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02823405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b Trial of X4P-001 Alone and With Pembrolizumab in Patients With Advanced Melanoma
Lead sponsor
X4 Pharmaceuticals
Phase
Phase 1
Overall status
Completed
Start date
September 15, 2016
Completion date
March 15, 2018
Enrollment
16 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma